David M. Frim to Nerve Growth Factors
This is a "connection" page, showing publications David M. Frim has written about Nerve Growth Factors.
Connection Strength
0.747
-
Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatum. Exp Neurol. 1994 Aug; 128(2):172-80.
Score: 0.123
-
Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc Natl Acad Sci U S A. 1994 May 24; 91(11):5104-8.
Score: 0.122
-
Striatal degeneration induced by mitochondrial blockade is prevented by biologically delivered NGF. J Neurosci Res. 1993 Jul 01; 35(4):452-8.
Score: 0.115
-
NGF reduces striatal excitotoxic neuronal loss without affecting concurrent neuronal stress. Neuroreport. 1993 Jun; 4(6):655-8.
Score: 0.114
-
Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. Neuroreport. 1993 Apr; 4(4):367-70.
Score: 0.113
-
Local protective effects of nerve growth factor-secreting fibroblasts against excitotoxic lesions in the rat striatum. J Neurosurg. 1993 Feb; 78(2):267-73.
Score: 0.111
-
Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 1995 Sep 11; 691(1-2):25-36.
Score: 0.033
-
Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. Cell Transplant. 1996 Mar-Apr; 5(2):225-32.
Score: 0.009
-
Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF). Brain Res. 1994 May 30; 647(1):30-6.
Score: 0.008